Olmetec: new angiotensin II blocker coming soonSchering-Plough will soon be launching Olmetec and Olmetec Plus for the treatment of mild to moderate hypertension. B.C. drug substitution plan cost more than it saved: study Pantoprazole: preferred PPI in patients taking clopidogrel A new Canadian Medical Association Journal study suggests that the interaction between clopidogrel and proton pump inhibitors is clinically significant. LAST LAUGH: Gearing up for life as a hockey mom There's a lot to learn as a rookie sports parent, including the order in which equipment is donned How to get a better sleep Doctor's CD program helps patients rest easy by teaching skills required for a good night's sleep MED2020 partners with CHIMA Offers HIM educational tool to colleges OPED: System collapse is a poor legacy for Quebec GPs Only quick action will help prevent ravages of looming retirement wave C. DIFFICILE: C. difficile trend trails flu season EDITORIAL: The perils of saving for retirement during a downturn POLITICS: Data may deserve critical eye, but kudos for effort, too First Previous 4038 4039 4040 4041 4042 Next Last
